PBH Prestige Consumer Healthcare Inc.
FY2025 10-K
Prestige Consumer Healthcare Inc. (PBH) filed its fiscal year 2025 10-K annual report with the SEC on May 9, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: Consumer healthcare products competing on brand recognition, quality, price, and availability through retail and e-commerce channels
- • Largest customers Walmart and Amazon accounted for 19% and 14% of revenues respectively, with top ten customers expected to increase share
Management Discussion & Analysis
- • Net cash from operations $251.5M, up $2.6M YoY; investing cash use $17.5M, down $2.7M; financing cash outflow $182.1M, down $58.9M
- • No reported revenue or profit/margin figures in section to analyze
Risk Factors
- • Legal risk from regulatory compliance with FASB ASC 280 and ASC 718 on goodwill and stock-based compensation valuation affecting reported assets and expenses
- • Macroeconomic threat from inflation, tariffs, and global supply chain disruptions causing shortages and price increases, notably impacting eye care product availability
Financial SummaryXBRL
Revenue
$1.1B
Net Income
$215M
Gross Margin
55.8%
Operating Margin
29.6%
Net Margin
18.9%
ROE
11.7%
Total Assets
$3.4B
EPS (Diluted)
$4.29
Operating Cash Flow
$252M
Source: XBRL data from Prestige Consumer Healthcare Inc. FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Prestige Consumer Healthcare Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.